Pfizer Launches GAI-Driven App to Improve Access to Healthcare

Pfizer has launched a GAI-driven Direct-to-Consumer platform that it hopes will usher in a new era of healthcare accessibility.

Pharmaceutical giant Pfizer has launched an AI-driven “direct-to-consumer” healthcare platform to simplify access to healthcare information and services.

Nearly two in every three Americans (65%) say coordinating and managing healthcare is overwhelming and time-consuming, Pfizer said in a news release, citing a poll by the American Academy of Physician Associates. According to the same poll, 73% of them feel the healthcare system is not meeting their needs. Direct-to-consumer (DTC) healthcare models are designed to make healthcare more accessible, affordable, and convenient by reducing barriers to access, empowering patients, and simplifying the healthcare journey.

Such DTC solutions are only made possible through the use of Generative AI (GAI) and Large Language Model (LLM) technologies.

By leveraging GAI technology, the DTC healthcare model can play a critical role in addressing the growing doctor shortage in the U.S. — one projected to reach a deficit of 86,000 physicians by 2036.

While a drug company like Pfizer may not be the first name that comes to mind in providing a DTC healthcare solution, James Allen, vice president U.S. Channel Management and Partnerships, Primary Care at Pfizer, said that its efforts during the pandemic earned the company significant consumer trust, and this trust became the cornerstone of Pfizer’s strategic pivot to direct-to-consumer healthcare.

“We’ve recognized the responsibility that comes with this trust. It’s not just about COVID — it’s about other therapeutic areas where patients are looking for reliable guidance,” Allen said. “Each patient wants to retain the right to choose their care path. We provide options, whether that’s telehealth, seeing a doctor in person, or getting enough information to return to their regular provider.”

The platform known as “Pfizer For All” key focus is on providing patients with optionality, or multiple paths to care, by giving patients to access healthcare information, the ability to connect with healthcare providers, as well as enabling them to manage treatments more easily.

While it’s only been a few weeks since the launch, as data comes in, Pfizer expects to make adjustments to the platform, learning more about patient needs and how best to serve them. “We don’t yet know what all the feedback will look like, but we’re open to learning from it and evolving the platform accordingly,” said Allen. “We’re watching engagement closely — how patients interact with the site, where they continue their journey, and what needs they express that we aren’t meeting yet.”

How BigRio Helps Bring LLM and Advanced AI Solutions to Healthcare

As the U.S. faces a shortage of primary care physicians and specialists, like Pfizer, we see how improving access to healthcare via innovative use of GAI is becoming more pressing now than ever.

BigRio has long been a facilitator and developer in leveraging AI to improve healthcare delivery, originally in the field of diagnostics and research. We have recently been focusing our efforts on supporting startups and developing our own solutions that use LLMs and GAI to improve those areas of healthcare, as well as direct patient interactions, customer relationship management, EMR integration, and so much more.

We are proud to have recently launched our proprietary LLM-driven tool, Odyssey Accelerator. It is a first-of-its-kind solution that enables businesses of all sizes who want to use GAI to transform the way they search or query enterprise data, design workflows, derive enterprise analytics, report generation, dashboards, and more, to build a proof of concept before scaling it enterprise-wide.

We believe that Generative AI will be most powerful when it is used to enhance, not substitute, human knowledge and creativity. For this reason, BigRio’s GenAI focus is on working with industry leaders and innovators to create custom tools that augment human intellect, allowing people to know more, do more, and create more than ever before. Customized Onsite, In-Person Healthcare-focused Learning & Ideation Workshops to Accelerate Your GenAI Journey : https://bigr.io/genai-workshops-for-healthcare-providers/

Leading healthcare IT innovator Vivid Health partnered with BigRio to develop an LLM-driven end-to- end solution, that today can assess a patient’s status on any combination of more than 100 chronic conditions across sixteen specialties, generating personalized care plans at scale in under 30 seconds. That’s over 75 million possible care plan combinations in a fraction of the time it typically takes to pull together individualized plans.

Vivid Health’s GAI-driven care management platform is currently the most powerful on the market. Its successful development and deployment stand as a testament to GAI’s potential to enhance the quality and efficiency of healthcare delivery.

You can read much more about how AI is redefining healthcare delivery and drug discovery in my book Quantum Care: A Deep Dive into AI for Health Delivery and Research. It’s a comprehensive look at how AI and machine learning are being used to improve healthcare delivery at every touchpoint.